234 related articles for article (PubMed ID: 18709567)
1. U-shaped dose response in behavioral pharmacology: historical foundations.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(7):591-8. PubMed ID: 18709567
[TBL] [Abstract][Full Text] [Related]
2. Dose-response features of neuroprotective agents: an integrative summary.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(4):253-348. PubMed ID: 18432419
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease drugs: an application of the hormetic dose-response model.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(5):419-51. PubMed ID: 18568864
[TBL] [Abstract][Full Text] [Related]
4. Pain and u-shaped dose responses: occurrence, mechanisms, and clinical implications.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(7):579-90. PubMed ID: 18709566
[TBL] [Abstract][Full Text] [Related]
5. The emergence of behavioral pharmacology.
Barrett JE
Mol Interv; 2002 Dec; 2(8):470-5. PubMed ID: 14993396
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological enhancement of neuronal survival.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(4):349-89. PubMed ID: 18432420
[TBL] [Abstract][Full Text] [Related]
7. Historical blunders: how toxicology got the dose-response relationship half right.
Calabrese EJ
Cell Mol Biol (Noisy-le-grand); 2005 Dec; 51(7):643-54. PubMed ID: 16359616
[TBL] [Abstract][Full Text] [Related]
8. Hormesis, adaptation, and the sandpile model.
Stark M
Crit Rev Toxicol; 2008; 38(7):641-4. PubMed ID: 18709573
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(5):473-87. PubMed ID: 18568867
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes: adaptive responses to low doses of neurotoxins.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(5):463-71. PubMed ID: 18568866
[TBL] [Abstract][Full Text] [Related]
11. Schedule-controlled behaviors as determinants of drug response.
Morse WH
Fed Proc; 1975 Aug; 34(9):1868-9. PubMed ID: 1149895
[TBL] [Abstract][Full Text] [Related]
12. Hormesis: why it is important to toxicology and toxicologists.
Calabrese EJ
Environ Toxicol Chem; 2008 Jul; 27(7):1451-74. PubMed ID: 18275256
[TBL] [Abstract][Full Text] [Related]
13. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications.
Calabrese EJ
Crit Rev Toxicol; 2005; 35(2-3):89-295. PubMed ID: 15839378
[TBL] [Abstract][Full Text] [Related]
14. Testing the hormetic nature of homeopathic interventions through stress response pathways.
Rattan SI; Deva T
Hum Exp Toxicol; 2010 Jul; 29(7):551-4. PubMed ID: 20558605
[TBL] [Abstract][Full Text] [Related]
15. Control of drug-taking behavior by schedules of reinforcement.
Kelleher RT; Goldberg SR
Pharmacol Rev; 1975 Sep; 27(3):291-9. PubMed ID: 817303
[No Abstract] [Full Text] [Related]
16. Stress biology and hormesis: the Yerkes-Dodson law in psychology--a special case of the hormesis dose response.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(5):453-62. PubMed ID: 18568865
[TBL] [Abstract][Full Text] [Related]
17. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
[TBL] [Abstract][Full Text] [Related]
18. Addiction and dose response: the psychomotor stimulant theory of addiction reveals that hormetic dose responses are dominant.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(7):599-617. PubMed ID: 18709568
[TBL] [Abstract][Full Text] [Related]
19. Drug effects and concurrent performances.
Catania AC
Pharmacol Rev; 1975 Sep; 27(3):385-94. PubMed ID: 1223911
[No Abstract] [Full Text] [Related]
20. When to respond? And how much? Temporal control and response output on mixed-fixed-interval schedules with unequally probable components.
Whitaker S; Lowe CF; Wearden JH
Behav Processes; 2008 Jan; 77(1):33-42. PubMed ID: 17628349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
